The company has received regulatory approval for an extension to the 44th Annual General Meeting.

This grants the company additional time to prepare for its key annual shareholder event.

This extension is significant for investors as it clarifies the revised timeline for the AGM, where important decisions and updates are typically shared.

It signals that the company has secured the necessary permissions to adjust its schedule for this crucial meeting.